Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
Archives of Gynecology and Obstetrics|December 19, 2008
Relapse and survival in early-stage ovarian cancerS Miriam Lenhard, A Bufe, C Kümper, et al.
Journal of Cancer Research and Clinical Oncology|January 7, 2010
Topoisomerase IIalpha expression rather than gene amplification predicts responsiveness of adjuvant anthracycline-based chemotherapy in women with primary breast cancerChristian Schindlbeck, D Mayr, C Olivier, et al.
Der Anaesthesist|December 6, 2005
Vasopressin as adjunct vasopressor for vasodilatory shock due to non-occlusive mesenteric ischemiaG Luckner, S Jochberger, V D Mayr, et al.
Critical Care Medicine|October 29, 2004
Vasopressin during cardiopulmonary resuscitation: a progress reportAnette C Krismer, Volker Wenzel, Karl H Stadlbauer, et al.
In Vivo (Athens, Greece)|January 3, 2012
Retinoid X receptor alpha (RXRα) and peroxisome proliferator-activated receptor gamma (PPARγ) expression in breast cancer: an immunohistochemical studyN Ditsch, T Vrekoussis, M Lenhard, et al.
Resuscitation|November 24, 2001
Effects of epinephrine in a pig model of hypothermic cardiac arrest and closed-chest cardiopulmonary resuscitation combined with active rewarmingE Kornberger, K H Lindner, V D Mayr, et al.
Journal of Cancer Research and Clinical Oncology|March 15, 2016
Trends in surgery and outcomes of squamous cell vulvar cancer patients over a 16-year period (1998-2013): a population-based analysisM Rottmann, T Beck, A Burges, et al.
Physics in Medicine and Biology|April 21, 2012
High-resolution breast tomography at high energy: a feasibility study of phase contrast imaging on a whole breastA Sztrókay, P C Diemoz, T Schlossbauer, et al.
Anesthesia and Analgesia|May 29, 2001
The effects of endogenous and exogenous vasopressin during experimental cardiopulmonary resuscitationA C Krismer, K H Lindner, V Wenzel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 7, 2011
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trialL Gladieff, A Ferrero, G De Rauglaudre, et al.
Pageof 13